Covid March 2020

From
Revision as of 10:11, 9 June 2020 by Bosmana (talk | contribs) (Created page with "==March== ===1 March (87,024 cases)=== * UN releases US$15 million for COVID-19 response ===2 March (89,068 cases)=== * [https://www.ecdc.europa.eu/en/publications-data/rapid...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

March

1 March (87,024 cases)

  • UN releases US$15 million for COVID-19 response

2 March (89,068 cases)

  • ECDC RRA COVID19 (#5)
    • Immediate activation of national emergency response mechanisms and pandemic preparedness plans to ensure containment and mitigation of COVID-19 with non-pharmaceutical public health measures.
    • Ensuring the general public is aware of the seriousness of COVID-19. A high degree of population understanding, community engagement and acceptance of the measures put in place (including more stringent social ** distancing) are key in preventing further spread.
    • Implementation of protocols for COVID-19 laboratory testing, diagnosis, surveillance and treatment.
    • Enhancement of surveillance, epidemiological investigation, close contact tracing, management of close contacts, immediate case detection and isolation.
    • Implementation of social distancing (e.g. the suspension of large-scale gatherings and the closure of schools and workplaces) to interrupt the chains of transmission.
    • Adapted risk communication and provision of adequate personal protective equipment for healthcare workers and rigorous application of infection prevention and control measures in healthcare facilities.
    • Provision of adequate healthcare capacity to isolate, support and actively treat patients.
    • Publishes COVID19 case definition (issues reported)
  • WHO:
    • Publishes COVID19 case definition (issues reported)
    • Mission of WHO experts arrive in Iran
    • “There’s no choice but to act now” (WHO, Dr Tedros)

3 March (90,664 cases))

  • Shortage of personal protective equipment endangering health workers worldwide

5 March (95,316 cases)

  • WHO: Director-General emphasized that the COVID-19 epidemic “can be pushed back, but only with a collective coordinated and comprehensive approach that engages the entire machinery of government.”

6 March (98,172 cases)

  • WHO publishes draft R&D blueprint draft for COVID-19
    • The R&D roadmap for COVID-19 outlines research priorities in 9 key areas. These include the natural history of the virus, epidemiology, diagnostics, clinical management, ethical considerations and social sciences, as well as longer-term goals for therapeutics and vaccines.

7 March (102,133 cases)

  • ECDC informs countries
    • In EU: 4738 cases / 140 deaths in 27 countries
  • WHO
    • Marking 100 000 cases worldwide

8 March (105,824 cases)

  • WHO:
    • Interim guidance on critical preparedness, readiness and response actions

9 March (109,695 cases)

  • WHO: “The rule of the game is: never give up.”
    • “We are not at the mercy of this virus,” said the WHO Director-General at the 9 March media briefing.
    • All countries must aim to stop transmission and prevent the spread of COVID-19, whether they face no cases, sporadic cases, clusters or community transmission.
    • “Let hope be the antidote to fear. Let solidarity be the antidote to blame. Let our shared humanity be the antidote to our shared threat"

10 March (114,232 cases)

  • ECDC Publishes Discharge criteria for confirmed COVID-19 cases
  • Answers to questions
    • What is the duration of SARS-CoV-2 virus shedding in bodily fluids of
      • Symptomatic patients after remission of symptoms?
      • Asymptomatic patients?
    • Which tests are available to document the lack of infectivity in a previously diagnosed infection?
    • What is the longest documented transmission from an asymptomatic person?
  • WHO:
    • Provides guidance to help people manage fear, stigma and discrimination during COVID-19
    • WHO issues schools guidance with UNICEF and IFRC

11 March (118,610 cases)

  • WHO declares a pandemic

12 March (125,497 cases)

  • ECDC Publishes Infection prevention and control for COVID-19 in healthcare settings
    • This update addresses the possible limited supply of personal protective equipment (PPE), hand hygiene materials, and environmental hygiene materials for healthcare facilities
  • ECDC RRA COVID19 (#6)
    • Need for immediate targeted action
      • Situation similar to China and Italy threatens to occur in other countries within days or weeks
    • Social distancing
      • Immediate isolation of suspect COVID19
      • Suspension of mass gathering
      • Teleworking
      • Closure of schools
      • Cordon sanitaire around communities with high transmission
    • Public awareness & solidarity
    • IPC in HealthCare
    • Train HCW who might be asked for support
    • Surveillance should focus on rapid case detection, shifting to assessing the effectiveness of community measures

13 March (133,852 cases)

14 March (143,227 cases)

  • ECDC informs countries
    • In EU: 22 753 cases / 1032 deaths in all countries

16 March (167,418 cases)

  • WHO: "You cannot fight a fire blindfolded.“
    • Countries should test every suspected case of COVID-19.
    • If people test positive, they should be isolated and the people they have been in close contact with up to 2 days before they developed symptoms should be sought out, and those people should be tested too if they show symptoms of COVID-19.
    • WHO also advises that all confirmed cases, even mild cases, should be isolated in health facilities, to prevent transmission and provide adequate care.
    • But we recognize that many countries have already exceeded their capacity to care for mild cases in dedicated health facilities.
    • In that situation, countries should prioritize older patients and those with underlying conditions.

17 March (180,163 cases)

  • ECDC Publishes Guidance for health system contingency planning during widespread transmission of SARS-CoV-2 with high impact on healthcare services
    • Approaches on how to increase capacity for managing COVID-19 cases in the context of widespread sustained SARS-CoV-2 transmission
  • WHO:
    • New guidance on people affected by humanitarian crises [2]
    • WHO calls for urgent, aggressive actions to combat COVID-19, as cases soar in South-East Asia Region

18 March (194,913 cases)

  • European Medicines Agency (EMA): (Also published by WHO)
    • On 18 March 2020, EMA published a statement on the use of non-steroidal anti-inflammatories for COVID-19. [3]
    • There is currently no scientific evidence establishing a link between ibuprofen and worsening of COVID‑19
  • More than 320 000 learners enroll in online COVID-19 courses
  • WHO Launch of SOLIDARITY trial

19 March (213,258 cases)

20 March (242,472 cases)

  • WHO: Young people "are not invincible"
    • Speaking at the COVID-19 media briefing, the Director-General said:
    • "Although older people are the hardest hit, younger people are not spared. Data from many countries clearly show that people under 50 make up a significant proportion of patients requiring hospitalization. Today, I have a message for young people: you are not invincible. This virus could put you in hospital for weeks, or even kill you. Even if you don’t get sick, the choices you make about where you go could be the difference between life and death for someone else. I’m grateful that so many young people are spreading the word and not the virus.“
  • WHO Health Alert for coronavirus launches on WhatsApp

21 March (271,241 cases)

  • ECDC informs countries
    • In EU: 74 362 cases / 3694 deaths in all countries

22 March (305,270 cases)

23 March (338,298 cases)

24 March (378,113 cases)

25 March (417,061 cases)

  • ECDC RRA COVID19 (#7)
    • In the present situation where COVID-19 is rapidly spreading in Europe, the current assessment is:
      • The risk of severe disease associated with COVID-19 for people in the EU/EEA and the UK is currently considered moderate for the general population and very high for older adults and individuals with chronic underlying conditions.
      • The risk of occurrence of widespread national community transmission of COVID-19 in the EU/EEA and the UK in the coming weeks is moderate if effective mitigation measures are in place and very high if insufficient mitigation measures are in place.
      • The risk of healthcare system capacity being exceeded in the EU/EEA and the UK in the coming weeks is considered high.
    • Measures taken at this stage should ultimately aim at protecting the most vulnerable population groups from severe illness and fatal outcome by reducing transmission in the general population and enabling the reinforcement of healthcare systems. Given the current epidemiology and risk assessment, and the expected developments in the next days to few weeks, the following public health measures to reduce the further spread and mitigate the impact of the pandemic should be applied in EU/EEA countries.
    • Maintain stringent measures until a ‘game-changer’ is developed, for example, a vaccine or a mass-produced, sensitive rapid diagnostic test.
    • Apply stringent measures until incidence drops to a certain threshold, then relax measures before reintroducing them before the hospital capacity threshold is reached again.
    • Identify a mix of measures that maintains incidence at slightly below hospital capacity, thereby reducing the overall number of cases.

26 March (467,710 cases)

27 March (528,025 cases)

  • The Switzerland based pharmaceutical company Roche releases the detailed guidelines on how to prepare the lysis buffer fluid for the COVID19 test, after pressure and negotiations with Dutch ministry of health. [6]
  • WHO WhatsApp health alert launches in Arabic, French and Spanish.
  • UK Prime Minister Boris Johnson tests positive for SARS-CoV2.

28 March (592,275)

29 March (656,444)

30 March (715,660)

31 March (777,798 cases)

  • ECDC publishes
    • "Infection prevention and control and preparedness for COVID-19 in healthcare settings" [8]
    • "Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union – second update" [9]
  • WHO warns about "Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19" [10]
  • ↑ Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim Guidance. WHO. 13 March 2020
  • ↑ Interim Guidance: SCALING-UP COVID-19 OUTBREAK READINESS AND RESPONSE OPERATIONS IN HUMANITARIAN SITUATIONS. Including Camps and Camp-Like Settings Version 1.1 March 2020 IFRC, IOM, UNHCR, WHO
  • ↑ EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. Press release 18/03/2020
  • ↑ Coronavirus disease 2019 (COVID-19) Situation Report – 63
  • ↑ Guiding principles for immunization activities during the COVID-19 pandemic: interim guidance. WHO. 26 March 2020
  • ↑ Roche deelt recept van vloeistof voor coronatests alsnog. NOS News. 27 March 2020
  • ↑ Infection prevention and control in the household management of people with suspected or confirmed coronavirus disease (COVID-19). ECDC Technical Report 30 March 2020
  • ↑ ECDC Technical Report. Infection prevention and control and preparedness for COVID-19 in healthcare settings. Third update – 31 March 2020
  • ↑ Contact tracing: Public health management of persons, including healthcare workers, having had contact with COVID-19 cases in the European Union – second update. 31 March 2020
  • ↑ Medical Product Alert N°3/2020 Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19
    • Retrieved from "https://corona.transmissible.eu/index.php?title=Covid_March_2020&oldid=873"